Beam Spin-Out Orbital Therapeutics Raises $270M to Advance RNA Portfolio
Orbital will use Series A funds to advance RNA-based vaccines, immunomodulators and protein replacement therapies.
Beam Spin-Out Orbital Therapeutics Raises $270M to Advance RNA Portfolio Read More »
